Pharmacoethnicity of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: a systematic review and meta-analysis

Treatment outcomes between FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) and GNP (gemcitabine with albumin-bound paclitaxel) as first-line chemotherapy regimens for metastatic pancreatic cancer (PC) were assessed according to ethnic groups categorized as Western or Asian subgr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yoon Suk, Lee, Jong-chan, Kim, Jae-Hyeong, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505398/
https://www.ncbi.nlm.nih.gov/pubmed/34635731
http://dx.doi.org/10.1038/s41598-021-99647-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505398/
https://www.ncbi.nlm.nih.gov/pubmed/34635731
http://dx.doi.org/10.1038/s41598-021-99647-5

Ejemplares similares